![Michael Cassano](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Loopbaan van Michael Cassano
Eerdere bekende functies van Michael Cassano
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Orasi Medical, Inc.
![]() Orasi Medical, Inc. Medical/Nursing ServicesHealth Services Orasi Medical, Inc. is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and monitor neurological diseases. They have developed a painless, non-invasive test that takes less than ten (10) minutes to administer and, based on the results of its current research, is more accurate than current clinical practice. Initially, its aim is to develop the first FDA cleared test for the diagnosis of Alzheimer's disease. In addition, they are developing products for pharmaceutical companies to measure treatment effect and reduce the cost of clinical drug trials for neurological diseases. Ultimately, its long-term goal is to set the standard of care for diagnosis and monitoring of major neurological diseases such as Alzheimer's disease, multiple sclerosis, Parkinson's, autism, depression and attention deficit hyperactivity disorder (ADHD). | Hoofd Techniek/Wetenschap/O&O | 20-04-2009 | 18-08-2012 |
JOHN WILEY & SONS, INC. | Corporate Officer/Principal | - | - |
Opleiding van Michael Cassano
University of Minnesota | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 4 |
Operationeel
Chief Tech/Sci/R&D Officer | 1 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sectoraal
Consumer Services | 3 |
Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
JOHN WILEY & SONS, INC. | Consumer Services |
Bedrijven in privébezit | 1 |
---|---|
Orasi Medical, Inc.
![]() Orasi Medical, Inc. Medical/Nursing ServicesHealth Services Orasi Medical, Inc. is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and monitor neurological diseases. They have developed a painless, non-invasive test that takes less than ten (10) minutes to administer and, based on the results of its current research, is more accurate than current clinical practice. Initially, its aim is to develop the first FDA cleared test for the diagnosis of Alzheimer's disease. In addition, they are developing products for pharmaceutical companies to measure treatment effect and reduce the cost of clinical drug trials for neurological diseases. Ultimately, its long-term goal is to set the standard of care for diagnosis and monitoring of major neurological diseases such as Alzheimer's disease, multiple sclerosis, Parkinson's, autism, depression and attention deficit hyperactivity disorder (ADHD). | Health Services |
- Beurs
- Insiders
- Michael Cassano
- Ervaring